Achieve Life Sciences (ACHV) Tops Q3 EPS by 40c; Reports Cash and Cash Equivalents of $33.4M

Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($0.71), $0.40 better than the analyst estimate of ($1.11).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Can global equities keep rising? UBS sees these factors driving upside
• Amneal gets FDA approval for lanreotide injection, launches immediately